Dr. Adolfo F Blanco , MD
General Practice • Miami, FL
11255 Sw 211th St
Miami, FL 331892240
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Adolfo Blanco is listed in NPPES under General Practice.
-
NPI assigned on October 4, 2006; this date does not establish years in practice.
-
Published CMS data list 527 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Lisinopril — 48 prescription fills, including refills.
- Atorvastatin Calcium — 43 prescription fills, including refills.
- Rosuvastatin Calcium — 43 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 26 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 75% of clinicians listed under General Practice in Miami, FL (2024, 155 clinicians with data). Median for this group: 2,748. Middle half: 534 to 8,097.
Fewer Part D prescriptions than 70% of clinicians listed under General Practice in Florida (2024, 1,276 clinicians with data). Median for this group: 2,849. Middle half: 518 to 6,924.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 760 in 2020 to 527 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
11255 Sw 211th St
Miami, FL 331892240
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
General Practice: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
1,330 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$27,875 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Industry payments (Open Payments)
Fewer than 11 payment records totaling $13.85 in 2024
Drug and medical device companies must report certain payments to doctors and some other clinicians to CMS, such as meals, travel, speaking fees or research funding.
It shows reported financial ties between this clinician and companies. You can ask your clinician about them.
These records are submitted by drug and medical device companies, and a reported payment does not necessarily mean the financial relationship is improper.
General: payments not tied to research, such as meals, travel, consulting or speaking fees.
A reported payment does not necessarily mean the financial relationship is improper. Research payments can go to a hospital or university for a study the clinician leads, not to the clinician personally. Clinicians can dispute records with the company that reported them.
Source: CMS Open Payments, program year 2024.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Blanco has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Blanco as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Miami and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 75% of clinicians listed under General Practice in Miami, FL (2024, 155 clinicians with data). Median for this group: 2,748. Middle half: 534 to 8,097.
Fewer Part D prescriptions than 70% of clinicians listed under General Practice in Florida (2024, 1,276 clinicians with data). Median for this group: 2,849. Middle half: 518 to 6,924.
Part D drug cost
A lower Part D drug cost than 70% of clinicians listed under General Practice in Miami, FL (2024, 155 clinicians with data). Median for this group: $165,864. Middle half: $21,215 to $482,159.
A lower Part D drug cost than 70% of clinicians listed under General Practice in Florida (2024, 1,276 clinicians with data). Median for this group: $166,180. Middle half: $16,824 to $452,832.
285 active clinicians are listed under General Practice with a practice address in Miami, FL (2,293 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Miami
9.1% of these 285 clinicians have the CMS telehealth indicator.
42.8% of these 285 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 31% from 760 in 2020 to 527 in 2024.
- 2020: 760
- 2021: 982
- 2022: 758
- 2023: 543
- 2024: 527
-
30-day fills
30-day fills decreased 38% from 2,134 in 2020 to 1,330 in 2024.
- 2020: 2,134
- 2021: 2,633
- 2022: 1,935
- 2023: 1,336
- 2024: 1,330
-
Part D drug cost
Part D drug cost increased 502% from $4,632 in 2020 to $27,875 in 2024.
- 2020: $4,632
- 2021: $21,132
- 2022: $49,988
- 2023: $25,572
- 2024: $27,875
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $23.44 in 2021 to $13.85 in 2024.
- 2021: $23.44
- 2023: $16.73
- 2024: $13.85
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2024), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2024 (payments made January 1 – December 31, 2024): fewer than 11 records totaling $13.85.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
PREVNAR 20 | General | $13.85 |
Source: CMS Open Payments, program year 2024, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Lisinopril | Lisinopril | 48 | 4,320 | $192.17 | 18 |
| Atorvastatin Calcium | Atorvastatin Calcium | 43 | 3,870 | $276.19 | 17 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 43 | 3,870 | $534.56 | 14 |
| Amlodipine Besylate | Amlodipine Besylate | 40 | 3,600 | $111.71 | 15 |
| Carvedilol | Carvedilol | 24 | 2,160 | $253.18 | — |
| Glipizide | Glipizide | 22 | 1,980 | $228.23 | — |
| Alendronate Sodium | Alendronate Sodium | 21 | 1,764 | $154.44 | — |
| Azithromycin | Azithromycin | 20 | 101 | $112.46 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 19 | 986 | $1,305.53 | — |
| Furosemide | Furosemide | 18 | 1,620 | $62.75 | — |
| Nifedipine Er | Nifedipine | 18 | 1,560 | $333.89 | — |
| Warfarin Sodium | Warfarin Sodium | 17 | 510 | $110.61 | — |
| Eliquis | Apixaban | 17 | 1,110 | $21,079.96 | — |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 17 | 170 | $180.32 | 12 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 16 | 667 | $1,327.63 | — |
| Metformin Hcl | Metformin Hcl | 16 | 1,440 | $70.57 | — |
| Pantoprazole Sodium | Pantoprazole Sodium | 16 | 1,440 | $153.26 | — |
| Ibuprofen | Ibuprofen | 15 | 128 | $24.76 | — |
| Metoprolol Tartrate | Metoprolol Tartrate | 14 | 1,260 | $73.39 | — |
| Glimepiride | Glimepiride | 13 | 1,170 | $0.00 | — |
| Novolin R | Insulin Regular, Human | 13 | 624 | $859.72 | — |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 12 | 1,080 | $155.88 | — |
| Gabapentin | Gabapentin | 12 | 1,020 | $89.97 | — |
| Simvastatin | Simvastatin | 11 | 990 | $42.90 | — |
| Allopurinol | Allopurinol | 11 | 690 | $85.74 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208D00000X
A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - GENERAL PRACTICE
I20180424002798
FL
8325352552
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Family
General Practice
Doctor of Medicine (M.D.)
Nurse Practitioner - Family
CRNPF
General Practice
General Practice
General Practice
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated October 04, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other General Practices in Miami
- Enrique Solis Lafont
- Dr. Anselmo Humaran, MD
- Dr. Geisha Garcia-Saez, MD
- Dr. Lidia Bello, MD
- Dr. Felix Chion-Fong, MD
- Dr. Ramon Hernandez, MD
Mailing Address
11255sw211th St
Miami, FL 331892240
Phone: 3052780200